Qureator, a leading AI-powered human disease model company, today announced the appointment of Dr. Branka Mitrovic as its new ...

The "Genomic Reference Materials and Controls Systems Market: Focus on Product Type, Application, End User, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

The rise of antibiotic resistance demands urgent research into its molecular mechanisms to inform the development of ...

Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional ...

Martin Makary, President Donald Trump’s pick to lead the US Food and Drug Administration, said he’s ready to carry out the ...

23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and ...

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...

Kyle Diamantas, a former corporate lawyer, is the new director for the F.D.A. food division, which oversees infant formula.

Drug developers' dreams of silencing RNA as a way to step in front of a range of diseases have not lived up to early-day hype ...

The decision reinstates unscientific regulation of new plant varieties, contradicting not only decades of experimentation, ...

Three studies led by faculty of Penn’s Perelman School of Medicine were selected for the Clinical Research Forum’s “Top Ten ...